Zobrazeno 1 - 10
of 731
pro vyhledávání: '"anticholinergic burden"'
Publikováno v:
Acta Pharmaceutica, Vol 74, Iss 2, Pp 329-341 (2024)
This study investigates the 10-year trend in the sedative and anticholinergic burden among older adults in Slovenia, with the aim of identifying opportunities to optimize pharmacotherapy in this population. A retrospective drug utilization analysis w
Externí odkaz:
https://doaj.org/article/b2d379355a6e47f18a043236be27522f
Autor:
Clara Martínez-Cao, Ainoa García-Fernández, Leticia González-Blanco, Pilar A. Sáiz, Julio Bobes, María Paz García-Portilla
Publikováno v:
Schizophrenia Research: Cognition, Vol 37, Iss , Pp 100317- (2024)
Background: Cognitive impairment is a widespread feature of schizophrenia, affecting nearly 80 % of patients. Prior research has linked the anticholinergic burden of psychiatric medications to these cognitive deficits. However, the impact of the anti
Externí odkaz:
https://doaj.org/article/deb9972f82714efb8806391cb826b27e
Publikováno v:
European Journal of Mental Health, Vol 19, Iss 0016, Pp 1-10 (2024)
Introduction: Pharmacotherapy in older adults with personality disorders (PDs) can be even more complicated compared to younger adults, because older adults stand at risk for polypharmacy and its negative consequences due to somatic comorbidities and
Externí odkaz:
https://doaj.org/article/9d4b260a647c42068d0c397b776dfee3
Autor:
Youn Huh, Ye-Jee Kim, Jung-Yeon Choi, Ji Eun Lee, Hee-Won Jung, Cheol Min Shin, Chang Won Won, Ki Young Son
Publikováno v:
BMC Geriatrics, Vol 24, Iss 1, Pp 1-9 (2024)
Abstract Background We aimed to evaluate the association of anticholinergic burden and chronic polypharmacy with the incidence of functional decline and all-cause mortality, and to determine the difference between anticholinergic burden and chronic p
Externí odkaz:
https://doaj.org/article/ca8daffc236e4054bb46b03160fc93d6
Publikováno v:
BMC Geriatrics, Vol 24, Iss 1, Pp 1-11 (2024)
Abstract Background Medications with potent anticholinergic properties have well-documented adverse effects. A high cumulative anticholinergic burden may arise from the concurrent use of multiple medications with weaker anticholinergic effects. We so
Externí odkaz:
https://doaj.org/article/a7fd462dde154a329956c81d11378634
Publikováno v:
BMC Geriatrics, Vol 23, Iss 1, Pp 1-9 (2023)
Abstract Background The aim of this study was to examine the risk of fall with the surrogate outcome of the Aachen Falls Prevention Scale and to assess the clinical pharmacist interventions in order to minimize anticholinergic drug burden and associa
Externí odkaz:
https://doaj.org/article/a5692b4ffcaa46fea44c8b73c1684f70
Autor:
Gulru Ulugerger Avci, Bahar Bektan Kanat, Gunay Can, Hakan Yavuzer, Deniz Suna Erdincler, Alper Doventas
Publikováno v:
Medicine Science, Vol 12, Iss 3, Pp 661-6 (2023)
We aimed to evaluate the association between polypharmacy, anticholinergic burden, comorbidities, and hospital length of stay in older adults. We analyzed 213 older in-patient data retrospectively. Demographic data, comorbidities, length of stay, med
Externí odkaz:
https://doaj.org/article/4453c68a1bbc4d5283aebee509347465
Publikováno v:
Medicine Science, Vol 12, Iss 3, Pp 674-9 (2023)
Acute appendicitis is one of the most common diseases treated with surgical methods worldwide. This study evaluated the reliability and quality of YouTube video content about appendicitis. To evaluate the reliability and quality of YouTube videos rel
Externí odkaz:
https://doaj.org/article/f46925ae2b4d46cc8d18fcc5dbd09c71
Autor:
Erken Neziha, Erken Ertugrul
Publikováno v:
Türk Biyokimya Dergisi, Vol 48, Iss 5, Pp 586-591 (2023)
Chronic kidney disease (CKD) is a condition characterized by atherosclerosis, cognitive impairment, physical limitations, biochemical abnormalities, and vascular aging. The proportion of those with a diagnosis of CKD in the older is increasing. With
Externí odkaz:
https://doaj.org/article/ad41167a753d4d7c92aaf795887d5dfb
Autor:
Romina Mahmoudi, Stephan Greten, Linda Veith Sanches, Lea Krey, Sarana Ulaganathan, Günter U. Höglinger, Johannes Heck, Florian Wegner, Martin Klietz
Publikováno v:
Brain Sciences, Vol 14, Iss 8, p 805 (2024)
Background: Anticholinergic adverse effects pose a relevant threat to patients, in particular elderly and cognitively impaired patients. Patients with Parkinsonian syndromes are especially at risk from anticholinergic adverse effects due to the often
Externí odkaz:
https://doaj.org/article/4964798184344823866905271889de3a